Fierce Pharma August 23, 2024
Ayla Ellison, Kevin Dunleavy

For the last 40 years, when federal legislation was ambiguous or left an administrative gap, courts were required to defer to the interpretation of agencies. This stipulation, called the Chevron deference, gave agencies room to advance their regulatory priorities.

The Supreme Court overturned the doctrine...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Govt Agencies, Pharma, Pharma / Biotech, Regulations, Trends
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
US health dept providing Moderna $590 mn to speed mRNA bird flu vaccine
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Insurer-PBM Firms Dominate Medicare Part D Market, Steering Patients to Their Pharmacies
Q&A: The Importance of ASHP’s 2025 Pharmacy Forecast

Share This Article